The Immune System’s Role in Fibromyalgia
Fibromyalgia, long dismissed as a psychological ailment, is now recognized as a measurable disease thanks to Dr. Bruce Gillis’s pioneering research. His 2012 study at the University of Illinois revealed that fibromyalgia patients have defective immune cells, specifically peripheral blood mononuclear cells, which fail to produce normal levels of critical proteins like cytokines. This discovery led to the FM/a Test, a groundbreaking blood test that validates the condition with objective biomarkers. Recent genomic studies further identified unique DNA signatures in patients, offering hope for targeted therapies. With links to conditions like long COVID, fibromyalgia’s immune basis demands urgent attention, especially given its high suicide risk.
